annual EBITDA:
-$150.57M-$50.04M(-49.77%)Summary
- As of today (May 29, 2025), VKTX annual EBITDA is -$150.57 million, with the most recent change of -$50.04 million (-49.77%) on December 31, 2024.
- During the last 3 years, VKTX annual EBITDA has fallen by -$95.19 million (-171.86%).
- VKTX annual EBITDA is now -123626.38% below its all-time high of -$121.70 thousand, reached on December 31, 2013.
Performance
VKTX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$55.47M-$9.34M(-20.25%)Summary
- As of today (May 29, 2025), VKTX quarterly EBITDA is -$55.47 million, with the most recent change of -$9.34 million (-20.25%) on March 31, 2025.
- Over the past year, VKTX quarterly EBITDA has dropped by -$21.47 million (-63.15%).
- VKTX quarterly EBITDA is now -3330.20% below its all-time high of $1.72 million, reached on December 31, 2014.
Performance
VKTX quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$172.04M-$21.47M(-14.26%)Summary
- As of today (May 29, 2025), VKTX TTM EBITDA is -$172.04 million, with the most recent change of -$21.47 million (-14.26%) on March 31, 2025.
- Over the past year, VKTX TTM EBITDA has dropped by -$57.98 million (-50.83%).
- VKTX TTM EBITDA is now -156875.36% below its all-time high of -$109.60 thousand, reached on December 31, 2012.
Performance
VKTX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
VKTX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -49.8% | -63.1% | -50.8% |
| 3 y3 years | -171.9% | -243.1% | -199.7% |
| 5 y5 years | -364.4% | -409.8% | -370.5% |
VKTX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -171.9% | at low | -245.5% | at low | -199.7% | at low |
| 5 y | 5-year | -364.4% | at low | -484.9% | at low | -370.8% | at low |
| alltime | all time | <-9999.0% | at low | -3330.2% | at low | <-9999.0% | at low |
VKTX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$55.47M(+20.3%) | -$172.04M(+14.3%) |
| Dec 2024 | -$150.57M(+49.8%) | -$46.13M(+26.5%) | -$150.57M(+12.7%) |
| Sep 2024 | - | -$36.47M(+7.3%) | -$133.66M(+7.5%) |
| Jun 2024 | - | -$33.98M(-0.1%) | -$124.38M(+9.0%) |
| Mar 2024 | - | -$34.00M(+16.4%) | -$114.07M(+13.5%) |
| Dec 2023 | -$100.53M(+43.5%) | -$29.21M(+7.4%) | -$100.53M(+9.8%) |
| Sep 2023 | - | -$27.19M(+14.9%) | -$91.53M(+13.9%) |
| Jun 2023 | - | -$23.67M(+15.6%) | -$80.40M(+8.1%) |
| Mar 2023 | - | -$20.46M(+1.3%) | -$74.36M(+6.1%) |
| Dec 2022 | -$70.06M(+26.5%) | -$20.21M(+25.9%) | -$70.06M(+12.5%) |
| Sep 2022 | - | -$16.05M(-8.9%) | -$62.29M(+4.6%) |
| Jun 2022 | - | -$17.63M(+9.0%) | -$59.56M(+3.8%) |
| Mar 2022 | - | -$16.17M(+30.0%) | -$57.40M(+3.6%) |
| Dec 2021 | -$55.39M(+30.7%) | -$12.43M(-6.7%) | -$55.39M(+2.3%) |
| Sep 2021 | - | -$13.33M(-13.8%) | -$54.15M(+7.0%) |
| Jun 2021 | - | -$15.47M(+9.3%) | -$50.59M(+13.4%) |
| Mar 2021 | - | -$14.16M(+26.4%) | -$44.61M(+7.9%) |
| Dec 2020 | -$42.38M(+30.7%) | -$11.20M(+14.6%) | -$41.33M(+6.1%) |
| Sep 2020 | - | -$9.77M(+3.0%) | -$38.94M(+6.6%) |
| Jun 2020 | - | -$9.48M(-12.8%) | -$36.54M(-0.1%) |
| Mar 2020 | - | -$10.88M(+23.5%) | -$36.56M(+12.8%) |
| Dec 2019 | -$32.43M | -$8.81M(+19.4%) | -$32.43M(+12.4%) |
| Sep 2019 | - | -$7.37M(-22.4%) | -$28.86M(+2.8%) |
| Jun 2019 | - | -$9.51M(+41.0%) | -$28.09M(+11.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$6.74M(+28.7%) | -$25.11M(+15.9%) |
| Dec 2018 | -$21.66M(+12.3%) | -$5.24M(-20.6%) | -$21.66M(+7.0%) |
| Sep 2018 | - | -$6.60M(+1.1%) | -$20.25M(+3.9%) |
| Jun 2018 | - | -$6.53M(+98.2%) | -$19.49M(+9.5%) |
| Mar 2018 | - | -$3.29M(-14.0%) | -$17.80M(-7.8%) |
| Dec 2017 | -$19.30M(+49.3%) | -$3.83M(-34.5%) | -$19.29M(+3.3%) |
| Sep 2017 | - | -$5.84M(+20.9%) | -$18.68M(+15.2%) |
| Jun 2017 | - | -$4.83M(+0.9%) | -$16.21M(+11.5%) |
| Mar 2017 | - | -$4.79M(+49.2%) | -$14.54M(+12.5%) |
| Dec 2016 | -$12.92M(-42.4%) | -$3.21M(-4.9%) | -$12.92M(-11.2%) |
| Sep 2016 | - | -$3.37M(+6.6%) | -$14.55M(-7.1%) |
| Jun 2016 | - | -$3.17M(-0.2%) | -$15.66M(-22.0%) |
| Mar 2016 | - | -$3.17M(-34.4%) | -$20.09M(-10.4%) |
| Dec 2015 | -$22.42M(+5.5%) | -$4.84M(+7.8%) | -$22.42M(+41.3%) |
| Sep 2015 | - | -$4.49M(-40.9%) | -$15.87M(+38.9%) |
| Jun 2015 | - | -$7.59M(+38.0%) | -$11.42M(-57.0%) |
| Mar 2015 | - | -$5.50M(-420.5%) | -$26.54M(+24.9%) |
| Dec 2014 | -$21.26M(>+9900.0%) | $1.72M(-4382.3%) | -$21.26M(-7.5%) |
| Sep 2014 | - | -$40.10K(-99.8%) | -$22.97M(+0.2%) |
| Jun 2014 | - | -$22.71M(>+9900.0%) | -$22.93M(+9576.2%) |
| Mar 2014 | - | -$220.00K(+1194.1%) | -$237.00K(+82.6%) |
| Dec 2013 | -$121.70K | - | - |
| Jun 2013 | - | -$17.00K(+431.3%) | -$129.80K(+15.1%) |
| Mar 2013 | - | -$3200.00(-97.1%) | -$112.80K(+2.9%) |
| Dec 2012 | - | -$109.60K | -$109.60K |
FAQ
- What is Viking Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Viking Therapeutics?
- What is Viking Therapeutics annual EBITDA year-on-year change?
- What is Viking Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Viking Therapeutics?
- What is Viking Therapeutics quarterly EBITDA year-on-year change?
- What is Viking Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Viking Therapeutics?
- What is Viking Therapeutics TTM EBITDA year-on-year change?
What is Viking Therapeutics annual EBITDA?
The current annual EBITDA of VKTX is -$150.57M
What is the all time high annual EBITDA for Viking Therapeutics?
Viking Therapeutics all-time high annual EBITDA is -$121.70K
What is Viking Therapeutics annual EBITDA year-on-year change?
Over the past year, VKTX annual EBITDA has changed by -$50.04M (-49.77%)
What is Viking Therapeutics quarterly EBITDA?
The current quarterly EBITDA of VKTX is -$55.47M
What is the all time high quarterly EBITDA for Viking Therapeutics?
Viking Therapeutics all-time high quarterly EBITDA is $1.72M
What is Viking Therapeutics quarterly EBITDA year-on-year change?
Over the past year, VKTX quarterly EBITDA has changed by -$21.47M (-63.15%)
What is Viking Therapeutics TTM EBITDA?
The current TTM EBITDA of VKTX is -$172.04M
What is the all time high TTM EBITDA for Viking Therapeutics?
Viking Therapeutics all-time high TTM EBITDA is -$109.60K
What is Viking Therapeutics TTM EBITDA year-on-year change?
Over the past year, VKTX TTM EBITDA has changed by -$57.98M (-50.83%)